GSK Price to Book Ratio 2010-2022 | GSK

Historical price to book ratio values for GSK (GSK) over the last 10 years. The current price to book ratio for GSK as of February 03, 2023 is 5.71.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

GSK Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2023-02-03 34.83 inf
2022-09-30 29.15 0.00
2022-06-30 53.31 0.00
2022-03-31 52.93 0.00
2021-12-31 52.82 $13.62 3.88
2021-09-30 45.20 0.00
2021-06-30 46.53 0.00
2021-03-31 41.15 0.00
2020-12-31 41.66 $12.40 3.36
2020-09-30 42.04 0.00
2020-06-30 45.02 0.00
2020-03-31 41.34 0.00
2019-12-31 50.60 $10.89 4.65
2019-09-30 45.44 0.00
2019-06-30 42.13 0.00
2019-03-31 43.47 0.00
2018-12-31 39.16 $2.28 17.19
2018-09-30 40.69 0.00
2018-06-30 40.34 0.00
2018-03-31 38.62 0.00
2017-12-31 34.44 $2.09 16.46
2017-09-30 38.87 0.00
2017-06-30 40.76 0.00
2017-03-31 39.40 0.00
2016-09-30 39.29 0.00
2016-06-30 39.07 0.00
2016-03-31 36.13 0.00
2015-12-31 34.86 0.00
2015-09-30 32.78 0.00
2015-06-30 35.05 0.00
2015-03-31 38.33 0.00
2014-12-31 34.99 0.00
2014-09-30 37.13 0.00
2014-06-30 42.61 0.00
2014-03-31 42.09 0.00
2013-12-31 41.50 0.00
2013-09-30 38.54 0.00
2013-06-30 37.98 0.00
2013-03-31 35.27 0.00
2012-12-31 32.19 0.00
2012-09-30 33.78 0.00
2012-06-30 32.92 0.00
2012-03-31 32.06 0.00
2011-12-31 31.98 0.00
2011-09-30 28.58 0.00
2011-06-30 29.34 0.00
2011-03-31 25.96 0.00
2010-12-31 26.08 0.00
2010-09-30 25.95 0.00
2010-06-30 22.05 0.00
2010-03-31 24.66 0.00
2009-12-31 26.64 0.00
2009-09-30 24.61 0.00
2009-06-30 21.75 0.00
2009-03-31 18.87 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $71.300B $36.279B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00